Key result
Recurrent sleep restriction in healthy men resulted in a biomarker profile associated with increased cardiovascular disease risk and altered the proteomic response to acute physical exercise.
Why the study?
It remained unclear whether blood levels of commonly measured cardiovascular disease biomarkers are sensitive to acute dynamic factors such as sleep restriction, physical exercise, and time of day.
Does sleep restriction alter levels of Olink-assessed blood biomarkers of cardiovascular risk in healthy men?
RCT (n=16)
Randomized crossover
No
Does sleep restriction alter levels of Olink-assessed blood biomarkers of cardiovascular risk in healthy men?
Short-term sleep restriction alters circulating cardiovascular biomarkers towards a profile associated with increased prospective CVD risk, highlighting the importance of sleep duration in cardiovascular health.
May elevate CVD risk via biomarkers in healthy men; hypothesis-generating, requires larger trials before clinical adoption.
Biomarker profiling from biofluids such as blood are widely measured in clinical research, using for example Olink proteomics panels. One such research focus area is cardiovascular disease (CVD), for which chronic sleep restriction (SR) is a risk factor. However, it remains unclear whether blood levels of commonly measured CVD biomarkers are sensitive to acute dynamic factors such as SR, physical exercise (PEx), and time of day. In this crossover design, 16 normal-weight, healthy men underwent three highly standardized in-lab nights of SR (4.25 h/night) and normal sleep (NS, 8.5 h/night) in randomized order, with 88 CVD blood protein biomarkers quantified using the Olink technology (and selected validation using ELISA) in the morning, evening, and immediately before and repeatedly after 30 min of high-intensity exercise. We found significant time-of-day-dependent changes in several CVD biomarkers. Whereas several proteins were exercise-induced across sleep conditions (such as the canonical exerkines IL- 6 and BDNF), exercise-induced proteomic dynamics differed in response to recurrent SR, compared with following NS. Moreover, SR compared with NS resulted in a biomarker profile previously associated with increased prospective risk of several CVDs across large-scale cohorts (such as higher circulating levels of IL-27 and LGALS9). Our findings highlight how dynamic physiology can modulate CVD biomarker levels. These results also underscore the need to consider sleep duration as a key determinant of cardiovascular health-an emphasis reflected in recent American Heart Association guidelines. Further studies in women, older individuals, and patients with prior CVD, and across different chronotypes and dietary schedules are warranted.
No takes yet. Share an insight, caveat, or question.
Brandão et al. (2025) conducted an RCT in Healthy (n=16). Sleep restriction vs. Normal sleep (8.5 h/night) was evaluated on Changes in 88 cardiovascular disease blood protein biomarkers. Recurrent sleep restriction in healthy men resulted in a biomarker profile associated with increased cardiovascular disease risk and altered the proteomic response to acute physical exercise.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: